Ischemic stroke. Cerebral infarction
Conditions
Interventions
Intervention 1: The first intervention group will receive ten micro gram per kilogram Filgrastim (produced by Cinnagen pharmaceutical company) in the form of intramuscular injection for three days. In
Treatment - Drugs
The first intervention group will receive ten micro gram per kilogram Filgrastim (produced by Cinnagen pharmaceutical company) in the form of intramuscular injection for three days
Intervention group 2 will receive 0.1 micro gram per kilogram Pegfilgrastim (produced by Cinnagen pharmaceutical company) in a single dose intramuscular injection
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 10 Years
Inclusion criteria
Inclusion criteria: Patients with leukemia, suffering from fever and neutropenia (NAC less than 1500)
Exclusion criteria
Exclusion criteria: Neutropenic patients other than leukemia patients who have not received the full course of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: At the beginning of the study, every other day until fever is stopped. Method of measurement: Using the Thermometer.;Neutropenia. Timepoint: At the beginning of the study, every other day until the ANC reaches over 1500. Method of measurement: Based on laboratory kits and based on the results of blood tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Hosseyn Rasoli
Kermanshah University of Medical Sciences
Outcome results
None listed